Patient Pain and Function in Medial Knee Osteoarthritis After Anteromedial vs Anterolateral Intra-Articular Corticosteroid Injection
Sponsor: University of Chicago • ClinicalTrials.gov ID: NCT07804446
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The primary purpose of this study is to find out if there is a difference in pain experienced in patients with knee arthritis of the inside of their knee if they get a steroid injection on the inside or outside of their knee. Participants will: 1. Be randomly divided into getting their steroid injection on the inside or outside of their knee. 2. Answer a pain survey before their injection as well as over the phone 2 weeks, 6 weeks, and 12 weeks after their injection.
Interventions
-
Anteromedial Injection
(Procedure)
If randomized to this intervention, patients will receive a corticosteroid injection in the anteromedial side of their knee.
-
Anterolateral Injection
(Procedure)
If randomized to this intervention, patients will receive a corticosteroid injection on the anterolateral side of their knee.
Eligibility criteria
Conditions
Locations
- Bolingbrook Clinic — Bolingbrook, Illinois, United States
- Hyde Park Clinic — Chicago, Illinois, United States
- La Grange Clinic — La Grange, Illinois, United States
- Orland Park Clinic — Orland Park, Illinois, United States
- Woodridge Clinic — Woodridge, Illinois, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record